BECTON, DICKINSON AND COMPANY

Lobbying for BECTON DICKINSON AND COMPANY

Filing · LD-2 quarterly report Q1 amendment

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Oct 20, 2026

Expenses

$780,000

What this organization spent lobbying with its own staff. Reported using IRS section 162(e) definitions (method C): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 8

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 5

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

Budget/Appropriations

Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization

Trade (domestic/foreign)

Issues related to medical device supply chain Issues related to international trade

Medicare/Medicaid

Issues related to reimbursement Issues related to CY2026 Home Health and DMEPOS PPS proposed rule and ANPRM on PPE and essential medicines

Health Issues

Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health Issues related to women's health Issues related to diagnostic testing

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.